Back to Search Start Over

Hypertension, antihypertensive medication use, and breast cancer risk in the California Teachers Study cohort

Authors :
Peggy Reynolds
Jason A. Zell
Hoda Anton-Culver
Argyrios Ziogas
Joan Largent
Susan L. Neuhausen
Pamela L. Horn-Ross
Sarah F. Marshall
Giske Ursin
Leslie Bernstein
Source :
Cancer Causes & Control, Largent, Joan A.; Bernstein, Leslie; Horn-Ross, Pamela L.; Marshall, Sarah F.; Neuhausen, Susan; Reynolds, Peggy; et al.(2010). Hypertension, antihypertensive medication use, and breast cancer risk in the California Teachers Study cohort. Cancer Causes & Control: An International Journal of Studies of Cancer in Human Populations, 21(10), pp 1615-1624. doi: 10.1007/s10552-010-9590-x. Retrieved from: http://www.escholarship.org/uc/item/9548j4gr, Largent, JA; Bernstein, L; Horn-Ross, PL; Marshall, SF; Neuhausen, S; Reynolds, P; et al.(2010). Hypertension, antihypertensive medication use, and breast cancer risk in the California teachers study cohort. Cancer Causes and Control, 21(10), 1615-1624. doi: 10.1007/s10552-010-9590-x. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/1d53x742
Publication Year :
2010
Publisher :
Springer Netherlands, 2010.

Abstract

Background: We investigated the association between hypertension, antihypertensive (AH) medication use, and breast cancer in a large prospective study, the California Teachers Study (CTS). Methods: Information on history of hypertension and lifetime regular use of AH medications was collected from 114,549 women in 1995-1996. Among them, 4,151 invasive breast cancers were diagnosed between 1995 and 2006. Additional information on AH use was collected from 73,742 women in 2000-2001, and 1,714 of these women were subsequently diagnosed with breast cancer. Cox proportional hazards regression was used to estimate relative risks (RR) and 95% confidence intervals (CI) for breast cancer. Results: Use of AH medication for ≥5 years, when compared with no use, was associated with a modest increased risk of invasive breast cancer (RR = 1.18, 95%CI 1.02-1.36). This increased risk appeared to be confined to estrogen receptor (ER)-positive tumors (RR = 1.21, 95%CI 1.03-1.43) and pre-/peri-menopausal women (RR = 1.58, 95%CI 1.11-2.25). Conclusions: Increased risk of invasive breast cancer was observed for long-term (≥5 years) AH use, and this appeared to be confined to ER + breast cancer and younger women. © 2010 The Author(s).

Details

Language :
English
ISSN :
15737225 and 09575243
Volume :
21
Issue :
10
Database :
OpenAIRE
Journal :
Cancer Causes & Control
Accession number :
edsair.doi.dedup.....d6e4bf8d5029a17c7ef6460b69619be8
Full Text :
https://doi.org/10.1007/s10552-010-9590-x.